Tuesday, February 28, 2017

Grape Seed Extracts Market 2023 - Industry Size, Share, Growth, Opportunities, Analysis and Forecast - Credence Research

According to a new market report published by Credence Research Inc., “Grape Seed Extracts Market (By Form Type (Powder, Liquid, and Gel), By Application (Food, Pharmaceuticals, Cosmetics and Others)) - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023”, the worldwide grape seed extracts market was valued at US$ 361.7 Mn in 2015. In terms of volume the global market stood at 463.6 tons in 2015.
Market Insights:
Rising awareness regarding the health benefits with the consumption of grape seed extracts is the major factor driving the market growth. Grape seed extracts plays a vital role in addressing health related issues such as skin damage,  blood pressure, cardiovascular issues and cancer. In addition, due to its anti-ageing and antioxidants properties coupled with rising demand for the natural and organic personal care and skin care products, will further propel the grape seed extracts market demand. Symptoms of allergies to some people when consumed are the key factor hampering the grape seed extracts market growth.
Expanding applications scope of grape seed extracts is projected to spur the market demand. Furthermore, changing demographics in emerging economies such as change in lifestyle, rise in disposable income, increasing awareness about the grape seed extracts and companies entering into these regions is projected to propel the market demand in the near future. Surging popularity of grape seed extracts globally, about it uses in medicines is also projected to boost the market demand.
Competitive Insights:
The major companies in grape seed extracts market are involved in new developments and innovations to increase the application scope of the grape seed extracts across various industries. Furthermore, companies are now expanding their manufacturing units over emerging economies as these economies offers huge growth potential. Some of the major players present in this market are Naturex, Botanic Innovations LLC., Polyphenolics, Augusto Bellinvia, Naturias, and Earthoil.
Key Trends:
  • Focus on targeting new application area for grape seed extracts
  • Emerging economies provides huge market potential
  • Enhancing new distribution channels
Latest Report:
About Us:
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States
Ph: 1-800-361-8290

at No comments:
Labels:

Real Time Location System (RTLS) Market 2022 - Global Industry Size, Share, Growth, Outlook, Analysis and Forecast - Credence Research

According to a new market report published by Credence Research Inc., “Real Time Location System (RTLS) Market (By End-use Vertical (Healthcare, Transportation and Logistics, Industrial Manufacturing & Processing, Government, Hospitality, Retail, and Other End-use Verticals), By Technology (RFID, Wi-Fi, ZigBee and UWB, GPS, Ultrasound, Infrared, and Other Technologies)) - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2022”, the global real time location system market is expected to grow at a CAGR of 38.6% during the forecast period 2015 to 2022.
Browse the full Real Time Location System (RTLS) (By End-use Vertical (Healthcare, Transportation and Logistics, Industrial Manufacturing & Processing, Government, Hospitality, Retail, and Other End-use Verticals), By Technology (RFID, Wi-Fi, ZigBee and UWB, GPS, Ultrasound, Infrared, and Other Technologies)) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2015 – 2022 report at http://www.credenceresearch.com/report/real-time-location-system-rtls-market
Market Insights
Real time location systems are technology driven systems that use tags and readers to identify, find, track, and manage the location of assets or people in real-time, generally within a confined area. To sustain profit margins and market position, enterprises are increasingly turning towards technology for increasing their asset utilization and operational efficiency. However, even after being in the market for over a decade, the technology hasn’t received enough acceptance. This majorly owes to issues like lack of interoperability between various technology infrastructures and uncertainty over return on investment. However, growing encouragement through government initiatives and heavy investments in the development of different tracking technologies are expected to propel market growth in the coming years.
Competitive Insights:
The global real time location system market is highly fragmented and technology driven, requiring vendors to understand distinct requirements and differences between varied end-use verticals. The leading four vendors accounted for less than 45% of the global real time location system market revenue in base year 2014. There exists high degree of competition amongst existing players. Some of the leading and promising players identified in the ecosystem include Stanley Healthcare Solutions (AeroScout Inc.) (the U.S.), Zebra Technologies Corporation (the U.S.), Ekahau, Inc. (the U.S.), Motorola Solutions Inc. (the U.S.), Awarepoint Corporation (the U.S.), Ubisense Group Plc (the U.K.), Identec Solutions (Liechtenstein), TeleTracking Technologies, Inc. (the U.S.), Versus Technology, Inc. (the U.S.) and  Savi Technology, Inc. (the U.S.) among others. Focus on developing robust and innovative solutions through research and development is the primary strategy adopted by the players in the market.
Key Trends:
  • Emergence and adoption of cost-effective technologies including ZigBee and Ultra Wideband
  • Popularity of smart factories to support adoption of real time location systems in the industrial sector
  • GPS and RFID technology not ideal for indoor location tracking
  • Issues including lack of interoperability and privacy concerns have posed biggest challenge to the growth of real time locating system market.
Latest Report:
About Us:
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States
Ph: 1-800-361-8290
at No comments:
Labels:

Global Laxatives Market Size, Growth, Share, Opportunities, Outlook, Analysis and Forecast 2022 - Credence Research

The latest market report published by Credence Research, Inc. “Global Laxatives Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the laxatives market was valued at USD 4,495.70 Mn in 2015, and is expected to reach USD 6,948.07 Mn by 2022, expanding at a CAGR of 5.6% from 2016 to 2022; where OTC drugs occupy the largest market share.
Browse the full report Global Laxatives Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 at http://www.credenceresearch.com/report/laxatives-market
Market Insights
Constipation is one of the most common conditions diagnosed in clinical practice, with up to one-fifth of the general population suffering from chronic constipation. Certain studies have reported 24% to 50% prevalence in older adults. It is also observed that between 10% and 18% geriatrics in community dwellings and 74% residents in nursing homes regularly use laxatives. Constipation can have significant impact on everyday functions and quality of life of patients. Severe cases of constipation may also lead to coronary episodes, cerebral ischemia and syncope. In order to mitigate the complications arising from uncontrolled or un-managed constipation, several types of laxatives are frequently prescribed to such patients, particularly to those belonging to the higher age group.
Among the various types of laxatives, several literatures indicate that osmotic laxatives demonstrate the best benefits to aged patients. Old age patients experience straining as dominant symptom of constipation. This symptom is well managed in majority of cases with administration of osmotic laxatives such as lactulose and polyethylene glycol. the polyethylene glycol laxatives market is expected to reach worth USD 1,271.98 Mn by 2022. The continuing expansion in the pool of geriatric population will increase the need for effective constipation management drugs.
In terms of geographic distribution, North America, constituting US and Canada is the largest regional market for laxatives. Largest contribution of North America in the overall pharmaceuticals market and higher prevalence of older adult constipation patients are the major characteristics of the region. Prevalence of constipation in the US is 1.9% to 27.2% with a median at 16%; whereas 50% to 74% elderly population under institutionalized care is reported to consume laxatives on a daily basis. High disease burden and ease of access to treatments is a prime growth driver for North America laxatives market. The North America laxatives market was valued at USD 2,171.41 Mn in 2015.
Latest Report:
About Us:
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States
Ph: 1-800-361-8290

at No comments:
Labels:

Global Irritable Bowel Syndrome With Diarrhea (IBS-D) Drugs Market Size, Growth, Share and Forecast 2022 - Credence Research

The latest market report published by Credence Research, Inc. “Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” the irritable bowel syndrome with diarrhea (IBS-D) drugs market was valued at USD 289.3 Mn in 2015, and is expected to reach USD 1,115.06 Mn by 2022, expanding at a CAGR of 13.89% from 2016 to 2022.
Browse the full report Irritable Bowel Syndrome with Diarrhea (IBS-D) Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 report at http://www.credenceresearch.com/report/irritable-bowel-syndrome-ibs-with-Diarrhea-drugs-market
Market Insights
Recent approvals for two new prescription drugs to treat irritable bowel syndrome with diarrhea (IBS-D) have become the biggest phenomenon in the IBS-D drugs market. These approvals are viewed as breakthrough step in the long struggle to discover effective treatment for IBS-D.
Viberzi (eluxadoline) assists in controlling bowel contractions thus containing diarrhea, whereas Xifaxan (rifaximin) is an antibiotic that treats diarrhea by altering the gut flora. Xifaxan had been used off label for treating IBS-D, thus direct approval for treating IBS-D will lead to growth in demand for Xifaxan during the forecast period. Drugs such as loperamide will experience a slack in demand due to the introduction of the said novel drugs.
Geographically, North America is the largest market for IBS-D drugs. Higher awareness about the disease, expected prompt availability of the newly approved drugs, better reimbursement system and higher IBS prevalence are the prime factors that drive the IBS-D drugs market in North America. On the other hand, Asia Pacific is expected to be the fastest growing regional market for IBS-D drugs. It is estimated that Asia Pacific market will progress at a CAGR of approximately 17% during the forecast period 2016-2022. Japan with its largest pool of geriatric population and with the anticipated approval for Xifaxan in 2018 makes the country the largest national market in Asia Pacific region. In addition, it is also estimated that due to factors such as moderate purchasing power in the patient population, lower diagnosis rates and poor disease awareness will contribute to sustained demand for OTC IBS-D drugs in the region. Regions such as Latin America and MENA are believed to follow the trends in Europe and North America market.
Commenting on the competitive scenario, the IBS-D drugs market is fragmented with no clear leader in terms of market revenue share. However, it is expected that with gradual approvals in the international markets, Valeant (Salix Pharmaceuticals) will emerge the market leader in the overall IBS drugs market with products for both IBS-D and IBS-C treatment.
Latest Report:
About Us:
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States
Ph: 1-800-361-8290

at No comments:
Labels:

Global Irritable Bowel Syndrome with Constipation (IBS-C) Drugs Market Size, Growth, Share and Forecast 2022 - Credence Research

According to the latest study published by Credence Research, Inc. “Global Irritable Bowel Syndrome with Constipation Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016-2022,” higher prevalence of IBS in developed world and prompt address to the need for advanced pharmaceutical measures will facilitate the dominance of Europe IBS-C drugs market on the global front.
Browse the full report Irritable Bowel Syndrome with Constipation (IBS-C) Drugs Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016–2022 at http://www.credenceresearch.com/report/irritable-bowel-syndrome-with-constipation-drugs-market
IBS is prevalent in general population across the globe for a long period and has affected adversely in terms of medical costs and socioeconomic impact. Increased prevalence of lifestyle related diseases, growth in healthcare spending, augmented patient population suffering from gastrointestinal diseases and medical advancements are the prime contributors to the growth of IBS-C drugs market.
Europe is a combination of varied market trends mutually prevalent across the comprising countries, attributed by the cultural mix and healthcare infrastructures.  The region has the largest share in the global IBS-C drugs market and was valued at USD 445.7 Mn in 2015. As IBS patient pool is the highest in the region, the demand for treatment options is also correspondingly high. The prevalence of IBS in European countries ranges from 5% to 25%.
IBS and CI are the two most common gastrointestinal disorders in North America. The conditions together affect more than 30 Million individuals as of 2014. North America also has the highest count of patients suffering from constipation. Evolved healthcare infrastructure, early bird commercialization of IBS-C drugs in the US, better reimbursement policies and higher awareness among both physicians and patient population are the major contributors to the dominance of North America in the global market.
In addition, Asia Pacific is expected to open further avenues for the international players in IBS-C market. APAC is emerging region with the huge scope for the pharmaceutical companies. Japan and China in particular are considered to be very promising countries for drugs market. As Asia is home to half of the world's population, and offers both a large relatively low-cost workforce in some countries and a potentially huge retail market, this region could be central to the future of the global economy.
APAC is the third largest market for the drugs of IBS are many big pharmaceutical companies are investing in for future growth. The number of patients suffering from irritable bowel syndrome accounts to almost 7% of the population. China has the largest market share for the drugs manufacturers in this region as this is one of the most potential markets for pharmaceutical giants and largest number of patients after Japan.
Latest Report:
About Us:
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States
Ph: 1-800-361-8290
at No comments:
Labels:

Flexible Electronics Market 2023 - Global Industry Size, Share, Growth, Opportunities, Analysis and Forecast - Credence Research

According to a new market report published by Credence Research, Inc., “Global Flexible Electronics Market (By Component (Flexible Display, Flexible Sensor, Flexible Battery, Flexible Memory, and Others (Photovoltaics, etc.)), By Application (Consumer Electronics, Automotive, Healthcare, Military and Defense, and Others (Energy, etc.)) - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 - 2023”, the global flexible electronics market is expected to expand at a double digit CAGR from 2016 to 2023.
Browse the “Global Flexible Electronics Market (By Component (Flexible Display, Flexible Sensor, Flexible Battery, Flexible Memory, and Others (Photovoltaics, etc.)), By Application (Consumer Electronics, Automotive, Healthcare, Military and Defense, and Others (Energy, etc.)) - Growth, Share, Opportunities, Competitive Analysis, and Forecast 2016 – 2023 report at http://www.credenceresearch.com/report/flexible-electronics-market
Key Market Insights:
The global flexible electronics market, still in infancy, is presumed to register robust growth, evolving beyond its early adopter stage and reach mass market by 2023. The on-going multitude of research in the field of flexible electronics will benefit the technology to expand its applications beyond consumer space into varied industry verticals in the coming years. Although the technology (flexible electronics) faces stern competition from the established technologies, superior benefits offered in terms of size (compactness), weight, portability, and energy efficiency would eventually enable it to prolong its existence in the market. Lack of standardized infrastructure necessary for manufacturing flexible electronic devices at small- and medium-sized manufacturing facilities poses a strong challenge to its widespread adoption in the current scenario.
Competitive Insights:
The global flexible electronics market is still in the infant stage of development and is highly competitive. Some of the leading players identified in the global flexible electronics market include 3M, Cymbet Corporation, E Ink Holdings Inc., First Solar, Front Edge Technologies, GE Measurement & Control Solutions, LG Electronics, Multi-Fineline Electronix, Inc., Pragmatic Printing Ltd., Blue Spark Technologies, Samsung Electronics Co., Ltd., AU Optronics, Solicore, Inc., Thinfilm Electronics ASA, and Enfucell among others. The global flexible electronics market also includes large base of niche players that account for trivial market share individually. The global flexible electronics market being technology driven, the competitive rivalry among market players is expected to remain high throughout the forecast period 2016 – 2023.
Major Strategies Adopted By Leading Industry Participant
  • Inorganic expansion through partnerships and acquisition. High level of integration between manufacturers and component suppliers.
  • Focus towards developing more advanced techniques to achieve economies of scale by manufacturing flexible electronic devices quickly and cost-effectively
  • To manufacture state-of-the-art flexible printed circuit boards and flexible displays for forthcoming potential applications
Latest Report:
About Us:
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States
Ph: 1-800-361-8290
at No comments:
Labels:

Global Enhanced Oil Recovery Market 2023 - Industry Size, Share, Growth,Outlook, Analysis and Forecast - Credence Research

According to a new market report published by Credence Research “Global Enhanced Oil Recovery Market- Growth, Future Prospects, Competitive Analysis, and Forecast 2016 - 2023,” the global enhanced oil recovery market has been estimated to be valued at US$ 45.8 Bn by the end of 2016, and is expected to reach US$ 159.5 Bn by 2023, expanding at a CAGR of 19.5% from 2016 to 2023.
Browse the full Global Enhanced Oil Recovery Market by Technology and Geography - Growth, Future Prospects, Competitive Analysis, and Forecast 2016 – 2023 report at http://www.credenceresearch.com/report/enhanced-oil-recovery-market
Market Insights
Enhanced Oil recovery (EOR) techniques are widely used to enhance the production of crude oil produced from a reservoir. In this process, the oil recovery is increased by injecting substance into the oil well to increase pressure and reduce viscosity of the crude oil. In conventional process, the recovery from oil well is approximately 30% of the oil reserve capacity whereas with EOR techniques upto 70% of the oil can be extracted from the reservoir. In case of heavy oil reservoir where crude extraction from primary recovery is difficult, enhanced oil recovery techniques such as thermal injection are widely used to enhance the oil recovery. However, this technique is not effective when the reservoirs are deep or too thin. Moreover, thermal injection technique requires high capital investment which may a feasible solution in case of smaller oil fields. Similarly, chemical injection techniques is one of the fastest growing techniques in enhance oil recovery market and are most effective to increase the yield in case of wet oil reservoirs. Increasing use of gas injection techniques as tertiary recovery method especially CO2 injection techniques are expected to intensify the growth of the enhanced oil recovery market till 2023.
Decline in oil prices in recent past has adversely affected the profit margin of oil producers. Thus, oil producers are concentrating on improving oil production from existing oil wells with the use of technologies such as enhance oil recovery this in turn is fueling the demand for enhance oil recovery techniques. Moreover, increasing number of matured reserves coupled with increasing production of shale gas is expected to augment the growth of enhanced oil recovery market. Besides this, gas injection technique provides added advantage for the commercial use of green house gases such as carbon dioxide (CO2) generated by various industries and power plants coupled with various government initiatives for the same disposal of green house gases is expected to drive the growth of enhanced oil recovery market over the forecast period 2016-2023.
Competitive Insights:
Global enhanced oil recovery market is segmented on the basis of technology such as thermal injection, gas injection and chemical injection. In 2015, thermal injection segment contributed the highest revenue share of the global enhanced oil recovery market. However, the segment has become matured and is expected to lose it market share to gas injection and chemical injection segment. The gas injection segment is anticipated to expand at a robust growth over the forecast period (2016-2023). Growing production of non-conventional shale gas and tight oil is fueling the demand for chemical injection segment. The segment is expected to register significant growth over the forecast period. Leading players in the global enhanced oil recovery market are involved in constantly innovating new techniques to enhance oil recovery from the reservoirs. Currently, matured reserve contributes over 65% of crude oil produced globally which indicates the future opportunities for enhance oil recovery technologies. Therefore, the global enhanced oil recovery market is projected to register robust CAGR over the forecast period (2016-2023).
Key Trends:
  • Merger & Acquisition
  • Development of new techniques
Latest Report:
About Us:
Credence Research is a worldwide industry research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
What we do
We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.
No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.
Contact:
Name: Chris Smith (Global Sales Manager)
Address: 105 N 1st ST #429, SAN JOSE,
CA 95103, United States
Ph: 1-800-361-8290
at No comments:
Labels:
Subscribe to: Posts (Atom)

Bone Cement Market | Major players are Zimmer Biomet, Stryker Corporation, DePuy Synthes, Cook Medical, DePuy Synthes, Smith & Nephew

The latest market report published by Credence Research, Inc. “ Bone Cement Market  –  Growth, Future Prospects, and Competitive Analysis,...